Paul Sanchez
Elixir Insurance, a subsidiary of Rite Aid, is not going out of business. However, Elixir's parent company, Rite Aid, is facing financial troubles and filed for Chapter 11 bankruptcy in 2023. As a result, Elixir is exiting the Prescription Drug Plan (PDP) market in 2024, discontinuing two of its plans: Elixir Rx Secure and Elixir RxPlus. This means that individuals enrolled in these plans will need to find alternative coverage, with support available through local agencies and insurance professionals. Despite the exit from the PDP market, Elixir Insurance continues to operate and serve its members as usual, and there is interest from MedImpact Healthcare in acquiring Elixir's pharmacy benefit manager business.
| Characteristics | Values |
|---|---|
| Elixir Insurance parent company | RiteAid |
| RiteAid's financial status | teetering on the brink of bankruptcy, $306 million loss |
| Elixir Insurance's status | continuing to operate and serve members as usual |
| Elixir Insurance's exit from PDP market | January 2024 |
| Elixir Rx plans no longer available | Elixir Rx Secure, Elixir RxPlus |
| Elixir acquisition bid | MedImpact Healthcare's $575 million stalking horse bid |
Explore related products
What You'll Learn
Elixir Rx Secure and Elixir RxPlus plans are no longer available in 2024
Elixir Rx Secure and Elixir RxPlus are two of the four stand-alone prescription drug plans (PDPs) that will no longer be offered in New York State in 2024. The other two plans that will be discontinued are Blue Rx Standard and Blue Rx Plus.
If you are currently enrolled in one of these plans, you have until February 28, 2024, to find and enroll in a new plan. You can change your coverage choice between October 15 and December 7, 2023, and your new coverage will begin on January 1, 2024.
You can find information on the new 2024 plans via the medicare.gov website or by calling 1-800-MEDICARE. These resources are available 24 hours a day, seven days a week. You can also reach out to local agencies and programs for help finding new insurance, such as the Office For the Aging or the Southwestern Independent Living Center. Remember that insurance companies also have staff available, including brokers and insurance agents, to help you make your decision. However, keep in mind that a broker can only discuss the products they offer.
The minimum coverage allowed for in the standard plan for 2024 includes a $545 deductible. It is important to review the changes to the PDPs in 2024 and understand how these may impact your current plan. While Elixir Insurance is facing challenges, with its parent company RiteAid facing financial difficulties, it is important to note that it is not included in Rite Aid's Chapter 11 process and is continuing to operate and serve its members as usual. There is also interest from MedImpact Healthcare, which has made a $575 million bid to acquire Rite Aid's Elixir business.
Safelite and Insurance: What's the Deal?
You may want to see also
Explore related products
Elixir's parent company, RiteAid, is facing bankruptcy
Rite Aid's bankruptcy will have a significant impact on the company and its subsidiaries. Elixir, as a subsidiary of Rite Aid, may face financial difficulties and operational challenges as a result. The company may be forced to restructure its business and make changes to its operations to reduce costs and improve efficiency. This could potentially result in job losses, changes to employee benefits, and a reduction in the company's ability to invest in new products and services.
Additionally, the bankruptcy may affect the company's relationships with its customers and suppliers. There may be concerns about the company's ability to honour its commitments and provide stable and reliable services. This could potentially lead to a loss of confidence in the company and a decline in its customer base. The bankruptcy may also impact the company's ability to secure favourable terms with suppliers, which could further affect its financial health and stability.
The impact of Rite Aid's bankruptcy on Elixir will depend on a number of factors, including the severity of the financial difficulties, the company's ability to restructure and adapt, and the support it receives from its stakeholders. It is important for Elixir to closely monitor the situation and take appropriate actions to mitigate any potential risks and ensure its long-term viability.
While Elixir Insurance is not directly included in the Chapter 11 process, it is important to note that the overall financial health and stability of Rite Aid may still have indirect effects on the subsidiary. Elixir may still face challenges and uncertainties as a result of the parent company's financial troubles, and it is crucial for them to closely monitor the situation and take proactive measures to ensure their stability and continuity of operations.
Parking Tickets: How They Affect Your Insurance Rates
You may want to see also
Explore related products
Elixir PBM will exit the PDP market in 2024
Elixir PBM, the pharmacy benefit manager business, will exit the prescription drug plan (PDP) market in 2024. Elixir's parent company, Rite Aid, is facing financial troubles, with losses amounting to $306 million. As a result, Elixir PBM will no longer offer its stand-alone prescription drug plans in New York State and other regions. This change will take effect in January 2024.
Elixir offers two PDP plans: Elixir Rx Secure and Elixir RxPlus. These plans will no longer be available as of 2024. Individuals currently enrolled in these plans for 2023 have a window of opportunity to find and enroll in a new plan. They can make this change between October 15 and February 28, 2024. Enrolling in a new plan between December 8 and December 31 will ensure that their new coverage begins on January 1, 2024.
The news of Elixir PBM's exit from the PDP market is concerning for those currently enrolled in their plans. However, there are alternative options available. The medicare.gov website and 1-800-MEDICARE are resources that can help individuals navigate their choices. Additionally, local agencies and programs, such as the Office for the Aging and the Southwestern Independent Living Center, can provide support in finding new insurance plans.
It is worth noting that Elixir Insurance, as a separate entity, is not included in Rite Aid's Chapter 11 process or the proposed transaction with MedImpact. Elixir Insurance continues to operate and serve its members as usual. There is also interest from MedImpact Healthcare, which has made a $575 million stalking horse bid to acquire Elixir PBM.
While Elixir PBM's exit from the PDP market will result in a reduction of plan options, those affected can take comfort in knowing that there are resources and support available to help them navigate this transition and find alternative coverage options.
Insurance Rates After an Accident: How High Will They Soar?
You may want to see also
Explore related products
MedImpact Healthcare has a $575 million bid to acquire Elixir
Elixir Insurance, owned by Rite Aid, is exiting the prescription drug plan (PDP) market in 2024 as Rite Aid filed for Chapter 11 bankruptcy protection in October 2023. Elixir Rx Secure and Elixir RxPlus are among the PDP plans that will no longer be available in 2024.
MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit management services in the US, has successfully completed the acquisition of Elixir Solutions. The $575 million bid was approved by the US Bankruptcy Court for the District of New Jersey Chief Judge Michael B. Kaplan. The acquisition was critical in safeguarding over 1,000 jobs at risk due to Rite Aid's bankruptcy and ensuring prescription service continuity for millions of Elixir members.
MedImpact's acquisition of Elixir is part of its ongoing reinvestment strategy and expands its portfolio of clinical, technology, health risk management, and consumer empowerment capabilities. MedImpact's vision is to provide better care and better costs, helping commercial and government health plans improve member health, manage total healthcare benefits, and reduce drug costs for millions of consumers nationwide.
MedImpact now serves more than 20 million members, processing over $40 billion in pharmacy transactions and investing hundreds of millions of dollars annually in people, innovation, and growth. The company has made several acquisitions over the past 18 months, expanding its technology and tools to curb specialty spend and enhance member health.
J&J's Insurance: Comprehensive Coverage
You may want to see also
Explore related products
Elixir Insurance is continuing to operate and serve members
Elixir Insurance is not going out of business. Despite its parent company, Rite Aid, facing financial troubles and filing for bankruptcy, Elixir Insurance is not part of Rite Aid's Chapter 11 process. In fact, Elixir Insurance will continue to operate and serve its members as usual. This means that existing policies will remain in force and new customers can continue to purchase insurance from the company.
Elixir Insurance's parent company, Rite Aid, has been facing financial difficulties. Rite Aid reported losses of $306 million, and its Elixir PBM business will exit the PDP market in January 2024. However, Elixir Insurance is a separate entity and is not included in Rite Aid's bankruptcy proceedings.
MedImpact Healthcare has made a $575 million bid to acquire Rite Aid's Elixir pharmacy benefit manager business. This potential acquisition further reinforces the separation between Rite Aid and Elixir Insurance, indicating that Elixir Insurance is not only continuing to operate but also has the potential to be acquired by another company.
While Elixir Insurance remains operational, there have been changes to some of its offerings. Specifically, two Elixir prescription drug plans (PDPs) will no longer be available in 2024. These plans are Elixir Rx Secure and Elixir RxPlus. This change affects individuals currently enrolled in these plans, who will need to find and enroll in a new plan. However, Elixir Insurance itself is still in business and serving its members.
In summary, despite the financial struggles of its parent company, Rite Aid, Elixir Insurance is continuing to operate and serve its members. The separation of Elixir Insurance from Rite Aid's bankruptcy proceedings and potential acquisition by MedImpact Healthcare further emphasize Elixir Insurance's ongoing operations. While there have been adjustments to specific Elixir PDP offerings, the insurance business itself remains active in the market.
Insurance Rates: Two Points, Big Impact
You may want to see also
Frequently asked questions
Elixir Insurance's parent company, Rite Aid, is facing bankruptcy and has announced that Elixir will exit the PDP market in January 2024. However, there is no indication that Elixir Insurance itself is going out of business.
As of October 2023, Elixir Insurance continues to operate and serve its members as usual.
Rite Aid is facing financial troubles and has reported losses of $306 million. The company is teetering on the brink of bankruptcy and exploring potential buyout options.
Yes, MedImpact Healthcare has made a $575 million stalking horse bid to acquire Rite Aid's Elixir pharmacy benefit manager business.
Yes, Elixir is discontinuing two of its Prescription Drug Plans (PDPs): Elixir Rx Secure and Elixir RxPlus. Individuals currently enrolled in these plans for 2023 have until February 28, 2024, to find and enroll in a new plan.
